2020-09-12 08:45:03 BdST
BD to get 100,000 free doses of Covid-19 vaccine from China
With pledges of a coronavirus vaccine, China is on a charm offensive to repair strained diplomatic ties and bolster engagement with other countries.
Bangladesh will get over 100,000 free doses of Covid-19 vaccine from a Chinese company. The Philippines will have quick access to a Chinese coronavirus vaccine. Latin American and Caribbean nations will receive $1 billion in loans to buy the medicine.
Never mind that China is still most likely months away from mass producing a vaccine that is safe for public use. The country is using the prospect of the drug’s discovery in a charm offensive aimed at repairing damaged ties and bringing friends closer in regions China deems vital to its interests.
Take, for example, Indonesia, which has long been wary of Beijing. China’s leader, Xi Jinping, assured the nation’s president, Joko Widodo, in a call last week: “China takes seriously Indonesia’s concerns and needs in vaccine cooperation.”
Xi hailed the two countries’ cooperation on developing a vaccine as “a new bright spot” in relations, according to a statement from China’s Foreign Ministry. “Together, China and Indonesia will continue to stand in solidarity against Covid-19,” he promised.
China’s vaccine pledges, on top of earlier shipments of masks and ventilators around the world, help it project itself as a responsible player as the United States retreats from global leadership. Beijing’s moves could also help it push back against accusations that the ruling Communist Party should be held responsible for its initial missteps when the coronavirus first emerged in China in December.
The ability to develop and deliver vaccines to poorer countries would also be a powerful signal of China’s rise as a scientific leader in a new post-pandemic global order.
“People are very willing to take a Chinese vaccine,” said Ghazala Parveen, a senior official at the National Institute of Health in Pakistan, where two Chinese vaccine makers are conducting trials. “In fact, we are being asked by people to have the vaccine ready as soon as possible.”
By some measures, China is leading the global race for a Covid-19 vaccine. It has four candidates in the last phase of clinical trials, more than any other country.
The United States has three vaccine candidates in late-stage trials, with Pfizer saying it could apply for emergency approval as early as October and Moderna saying it hopes to have a vaccine by the end of the year. AstraZeneca, a British-Swedish company that received U.S. government funding to develop its vaccine, paused its late-stage global trials this week because of a serious suspected adverse reaction in a participant.
China has approved at least two experimental vaccines under an emergency use program that started in July with soldiers and employees of state-owned companies and has quietly expanded to include health care and aviation workers. Its vaccine makers have built factories that can produce hundreds of thousands of doses.
Unauthorized use or reproduction of The Finance Today content for commercial purposes is strictly prohibited.